Our objective is to develop and bring to market the most promising medicines based on the transformative potential of combining targeted therapies with immune therapies. At the core of this effort is our unique approach that combines talented people with a deep understanding of b-cell diseases and an unrelenting desire to identify the best compounds to attack b-cell diseases.
At bluebird, we’re working on incredibly cool things that matter – it’s crazy to think about the effect our science may have on someone’s life. There’s nothing more important than helping people who are suffering, and we have an opportunity to make a real difference.
Sally from Accounting